Latest Conference Articles

Impact of HIV on Brain Structure and Function

Impact of HIV on Brain Structure and Function

March 10th 2021, 6:27pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

Deep learning models identified the largest differences in resting state network topology occurred.

Neutralizing Antibodies in SARS-CoV-2 Infected Children

Neutralizing Antibodies in SARS-CoV-2 Infected Children

March 10th 2021, 4:43pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

Plasma proteome confirmed the association between cellular and humoral SARS-CoV-2 immunity.

Proteomics May Identify Proteins Predictive of HIV Mortality

Proteomics May Identify Proteins Predictive of HIV Mortality

March 10th 2021, 2:48pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

The prognostic proteins identified can serve as the basis of future pathway and network analyses.

COVID-19 and Viral Suppression

COVID-19 and Viral Suppression

March 9th 2021, 10:47pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

During the pandemic, reduced HIV testing led to concerns about getting people diagnosed and on antiretroviral therapy (ART), and achieving viral suppression (VS).

Men Report Worse Respiratory, Inflammatory Status with SARS-CoV-2 than Women

Men Report Worse Respiratory, Inflammatory Status with SARS-CoV-2 than Women

March 9th 2021, 10:35pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

Johns Hopkins data suggest men are being hospitalized more frequently with infection, and are facing more severe outcomes.

Single Dose of mRNA Vaccine May be Enough for COVID-19 Experienced People

Single Dose of mRNA Vaccine May be Enough for COVID-19 Experienced People

March 9th 2021, 9:19pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

MN titers showed a striking increase after just 1 dose in experienced subjects.

Using the MINMON Approach as a Safe and Simple Treatment for HCV

Using the MINMON Approach as a Safe and Simple Treatment for HCV

March 9th 2021, 7:32pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

COVID-19 has further highlighted the need for innovative models that minimize face-to-face contact in HCV treatment.

HIV Maturation Inhibitor Findings Presented

HIV Maturation Inhibitor Findings Presented

March 9th 2021, 7:00pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

ViiV Healthcare’s investigational therapy, GSK’254, demonstrated antiviral activity, safety, and tolerability in its phase 2a proof-of-concept findings.

Treating COVID-19 with Potent Neutralizing Antibodies

Treating COVID-19 with Potent Neutralizing Antibodies

March 9th 2021, 6:00pm

Annual Conference on Retroviruses and Opportunistic Infections (CROI)

Convalescent plasma treatment was found not to improve survival or disease course in the patient group.